Anaphylactoid reaction to intravenous methylprednisolone in a patient with multiple sclerosis

VAN DEN BERG, J. S. P.; VAN EIKEMA HOMMES, O. R.; WUIS, E. W.; STAPEL, S.; VAN DER VALK, P. G. M.; van den Berg, J S; van der Valk, P G
December 1997
Journal of Neurology, Neurosurgery & Psychiatry;Dec1997, Vol. 63 Issue 6, p813
Academic Journal
case study
No abstract available.


Related Articles

  • Methylprednisolone.  // Reactions Weekly;Nov2015, Vol. 1579 Issue 1, p264 

    The article describes the cases of adult patients with multiple sclerosis (MS) who developed hepatotoxicity after high-dose intravenous methylprednisolone infusions for disease exacerbations, referencing research published in the "Multiple Sclerosis Journal."

  • Therapy — immunosuppression.  // Multiple Sclerosis (13524585);Sep2005 Supplement, Vol. 11, p169 

    Discusses abstracts of studies about the role of immunosuppression in the treatment of multiple sclerosis, published in the October 2005 issue of the periodical "Multiple Sclerosis". "Comparison of Different Durations of High-Dose Intravenous Methylprednisolone Regimes in Moderate Relapses of...

  • Suppressive effect of glucocorticoids on TNF-α production is associated with their clinical effect in multiple sclerosis. van Winsen, Lisa M. L.; Polman, Chris H.; Christine D. Dijkstra; Tilders, Fred J. H.; Uitdehaag, Bernard M. J. // Multiple Sclerosis (13524585);Apr2010, Vol. 16 Issue 4, p500 

    A reduced sensitivity to glucocorticoids can affect the clinical effect of treatment with high-dose intravenous methylprednisolone in multiple sclerosis. We prospectively studied 27 multiple sclerosis patients who were treated with intravenous methylprednisolone. Before and after treatment in...

  • Anaphylaxis and mastocytosis. RUSSELL, W. J. // Anaesthesia & Intensive Care;Nov2009, Vol. 37 Issue 6, p1037 

    A letter to the editor is presented in response to the article "Anaphylactoid Reaction to Intravenous Contrast in Patient With Systemic Mastocystosis," by T. N. Weingarter and colleagues, published in the 2009 issue.

  • Anaphylaxis and mastoeytosis -- Reply. WEINGARTEN, T. N.; VOLCHECK, G. W.; SPRUNG, J. // Anaesthesia & Intensive Care;Nov2009, Vol. 37 Issue 6, p1037 

    A response by T. N. Weingarter and colleagues to a letter to the editor about their article "Anaphylactoid Reaction to Intravenous Contrast in Patient With Systemic Mastocystosis," published in the 2009 issue, is presented.

  • Oral vs. IV steroids in acute relapses of multiple... Walling, Anne D. // American Family Physician;9/1/1997, Vol. 56 Issue 3, p914 

    Presents a summary of the work `Randomized Trial of Oral and Intravenous Methylprednisolone in Acute Relapses of Multiple Sclerosis,' by D. Barnes, et al. from `Lancet' dated 1997.

  • Methylprednisolone.  // Reactions Weekly;5/26/2007, Issue 1153, p20 

    The article describes the case of a 54-year-old woman who developed acute hepatic necrosis while under methylprednisolone treatment regimen for multiple sclerosis. After receiving her second intravenous methylprednisolone course, the patient experienced dark urine, jaundice and vomiting....

  • Development of a relapse clinic for people with multiple sclerosis. Craig, Jenny // British Journal of Therapy & Rehabilitation;Sep2002, Vol. 9 Issue 9, p333 

    Reports the plans of developing a relapse clinic for people with multiple sclerosis in Liverpool, England. Emphasis on multidisciplinary team management; Use of outcome measures to assess impairment, disability and quality of life of patients receiving intravenous methylprednisolone;...

  • Etanercept.  // Reactions Weekly;11/15/2008, Issue 1228, p18 

    The article describes the case of a 36-year-old woman who acquired multiple sclerosis (MS). The patient, who has ankylosing spondylitis, developed the said condition while undergoing treatment with etanercept. In the past, she had optic neuritis which was treated through intravenous (IV)...

  • IVIG trials in MS. Is albumin a placebo? Hommes, Otto; Haas, Judith; Soelberg-Sorenson, Per; Friedrichs, Mieke // Journal of Neurology;Feb2009, Vol. 256 Issue 2, p268 

    A letter to the editor is presented on the effects of intravenous immunoglobulin treatments for multiple sclerosis patients.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics